24 results on '"Sanderson-Smith, Martina L."'
Search Results
2. A Key Role for the Urokinase Plasminogen Activator (uPA) in Invasive Group A Streptococcal Infection.
- Author
-
Sanderson-Smith, Martina L., Zhang, Yueling, Ly, Diane, Donahue, Deborah, Hollands, Andrew, Nizet, Victor, Ranson, Marie, Ploplis, Victoria A., Walker, Mark J., and Castellino, Francis J.
- Subjects
- *
UROKINASE , *PLASMINOGEN activators , *STREPTOCOCCAL diseases , *BACTERIAL diseases , *PATHOGENIC microorganisms - Abstract
Recruitment of the serine protease plasmin is central to the pathogenesis of many bacterial species, including Group A streptococcus (GAS), a leading cause of morbidity and mortality globally. A key process in invasive GAS disease is the ability to accumulate plasmin at the cell surface, however the role of host activators of plasminogen in this process is poorly understood. Here, we demonstrate for the first time that the urokinase-type plasminogen activator (uPA) contributes to plasmin recruitment and subsequent invasive disease initiation in vivo. In the absence of a source of host plasminogen activators, streptokinase (Ska) was required to facilitate cell surface plasmin acquisition by GAS. However, in the absence of Ska, host activators were sufficient to promote cell surface plasmin acquisition by GAS strain 5448 during incubation with plasminogen or human plasma. Furthermore, GAS were able mediate a significant increase in the activation of zymogen pro-uPA in human plasma. In order to assess the contribution of uPA to invasive GAS disease, a previously undescribed transgenic mouse model of infection was employed. Both C57/black 6J, and AlbPLG1 mice expressing the human plasminogen transgene, were significantly more susceptible to invasive GAS disease than uPA−/− mice. The observed decrease in virulence in uPA−/−mice was found to correlate directly with a decrease in bacterial dissemination and reduced cell surface plasmin accumulation by GAS. These findings have significant implications for our understanding of GAS pathogenesis, and research aimed at therapeutic targeting of plasminogen activation in invasive bacterial infections. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
3. Bacterial Plasminogen Receptors: Mediators of a Multifaceted Relationship.
- Author
-
Sanderson-Smith, Martina L., De Oliveira, David M. P., Ranson, Marie, and McArthur, Jason D.
- Abstract
Multiple species of bacteria are able to sequester the host zymogen plasminogen to the cell surface. Once localised to the bacterial surface, plasminogen can act as a cofactor in adhesion, or, following activation to plasmin, provide a source of potent proteolytic activity. Numerous bacterial plasminogen receptors have been identified, and the mechanisms by which they interact with plasminogen are diverse. Here we provide an overview of bacterial plasminogen receptors and discuss the diverse role bacterial plasminogen acquisition plays in the relationship between bacteria and the host. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
4. Bacterial Plasminogen Receptors: Mediators of a Multifaceted Relationship.
- Author
-
Sanderson-Smith, Martina L., De Oliveira, David M. P., Ranson, Marie, and McArthur, Jason D.
- Subjects
- *
FIBRINOLYTIC agents , *CELL receptors , *METABOLISM - Abstract
Multiple species of bacteria are able to sequester the host zymogen plasminogen to the cell surface. Once localised to the bacterial surface, plasminogen can act as a cofactor in adhesion, or, following activation to plasmin, provide a source of potent proteolytic activity. Numerous bacterial plasminogen receptors have been identified, and the mechanisms by which they interact with plasminogen are diverse. Here we provide an overview of bacterial plasminogen receptors and discuss the diverse role bacterial plasminogen acquisition plays in the relationship between bacteria and the host. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. Parameters Governing Invasive Disease Propensity of Non-M1 Serotype Group A Streptococci.
- Author
-
Maamary, Peter G., Sanderson-Smith, Martina L., Aziz, Ramy K., Hollands, Andrew, Cole, Jason N., McKay, Fiona C., McArthur, Jason D., Kirk, Joshua K., Cork, Amanda J., Keefe, Rachael J., Kansal, Rita G., Sun, Hongmin, Taylor, William L., Chhatwal, Gursharan S., Ginsburg, David, Nizet, Victor, Kotb, Malak, and Walker, Mark J.
- Published
- 2010
- Full Text
- View/download PDF
6. The Maintenance of High Affinity Plasminogen Binding by Group A Streptococcal Plasminogen-binding M-Iike Protein Is Mediated by Arginine and Histidine Residues within the a1 and a2 Repeat Domains.
- Author
-
Sanderson-Smith, Martina L., Walker, Mark J., and Ranson, Marie
- Subjects
- *
PLASMINOGEN , *RADIOGENETICS , *FIBRINOLYTIC agents , *MUTAGENESIS , *GENETIC mutation , *BIOCHEMISTRY - Abstract
Subversion of the plasminogen activation system is implicated in the virulence of group A streptococci (GAS). GAS displays receptors for the human zymogen plasminogen on the cell surface, one of which is the plasminogen-binding group A streptococcal M-like protein (PAM). The plasminogen binding domain of PAM is highly variable, and this variation has been linked to host selective immune pressure. Site-directed mutagenesis of full-length PAM protein from an invasive GAS isolate was undertaken to assess the contribution of residues in the a1 and a2 repeat domains to plasminogen binding function. Mutagenesis to alanine of key plasminogen binding lysine residues in the a1 and a2 repeats (Lys98 and Lys111) did not abrogate plasminogen binding by PAM nor did additional mutagenesis of Arg101 and His102 and Glu104, which have previously been implicated in plasminogen binding. Plasminogen binding was only abolished with the additional mutagenesis of Arg114 and His115 to alanine. Furthermore, mutagenesis of both arginine (Arg101 and Arg114) and histidine (His102 and His115) residues abolished interaction with plasminogen despite the presence of Lys98 and Lys111 in the binding repeats. This study shows for the first time that residues Arg101, Arg114, His102, and His115 in both the a1 and a2 repeat domains of PAM can mediate high affinity plasminogen binding. These data suggest that highly conserved arginine and histidine residues may compensate for variation elsewhere in the a1 and a2 plasminogen binding repeats, and may explain the maintenance of high affinity plasminogen binding by naturally occurring variants of PAM. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
7. The Maintenance of High Affinity Plasminogen Binding by Group A Streptococcal Plasminogen-binding M-Iike Protein Is Mediated by Arginine and Histidine Residues within the al and a2 Repeat Domains.
- Author
-
Sanderson-Smith, Martina L., Mark J. Walker, and Ranson, Marie
- Subjects
- *
PLASMINOGEN activators , *STREPTOCOCCAL diseases , *STREPTOCOCCUS , *ARGININE , *MUTAGENESIS , *PROTEIN binding , *THERAPEUTICS - Abstract
Subversion of the plasminogen activation system is implicated in the virulence of group A streptococci (GAS). GAS displays receptors for the human zymogen plasminogen on the cell surface, one of which is the plasminogen-binding group A streptococcal M-like protein (PAM). The plasminogen binding domain of PAM is highly variable, and this variation has been linked to host selective immune pressure. Site-directed mutagenesis of full-length PAM protein from an invasive GAS isolate was undertaken to assess the contribution of residues in the a1 and a2 repeat domains to plasminogen binding function. Mutagenesis to alanine of key plasminogen binding lysine residues in the a1 and a2 repeats (Lys98 and Lys111) did not abrogate plasminogen binding by PAM nor did additional mutagenesis of Arg101 and His102 and Glu104, which have previously been implicated in plasminogen binding. Plasminogen binding was only abolished with the additional mutagenesis of Arg114 and His115 to alanine. Furthermore, mutagenesis of both arginine (Arg101 and Arg114) and histidine (His102 and His115) residues abolished interaction with plasminogen despite the presence of Lys98 and Lys111 in the binding repeats. This study shows for the first time that residues Arg101, Arg114, His102, and His115 in both the a1 and a2 repeat domains of PAM can mediate high affinity plasminogen binding. These data suggest that highly conserved arginine and histidine residues may compensate for variation elsewhere in the a1 and a2 plasminogen binding repeats, and may explain the maintenance of high affinity plasminogen binding by naturally occurring variants of PAM. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
8. An optimised GAS-pharyngeal cell biofilm model.
- Author
-
Vyas, Heema K. N., McArthur, Jason D., and Sanderson-Smith, Martina L.
- Subjects
- *
STREPTOCOCCUS , *BIOFILMS , *VIRULENCE of bacteria , *BIOMASS , *BACTERIAL cells - Abstract
Group A Streptococcus (GAS) causes 700 million infections and accounts for half a million deaths per year. Biofilm formation has been implicated in both pharyngeal and dermal GAS infections. In vitro, plate-based assays have shown that several GAS M-types form biofilms, and multiple GAS virulence factors have been linked to biofilm formation. Although the contributions of these plate-based studies have been valuable, most have failed to mimic the host environment, with many studies utilising abiotic surfaces. GAS is a human specific pathogen, and colonisation and subsequent biofilm formation is likely facilitated by distinct interactions with host tissue surfaces. As such, a host cell-GAS model has been optimised to support and grow GAS biofilms of a variety of GAS M-types. Improvements and adjustments to the crystal violet biofilm biomass assay have also been tailored to reproducibly detect delicate GAS biofilms. We propose 72 h as an optimal growth period for yielding detectable biofilm biomass. GAS biofilms formed are robust and durable, and can be reproducibly assessed via staining/washing intensive assays such as crystal violet with the aid of methanol fixation prior to staining. Lastly, SEM imaging of GAS biofilms formed by this model revealed GAS cocci chains arranged into three-dimensional aggregated structures with EPS matrix material. Taken together, we outline an efficacious GAS biofilm pharyngeal cell model that can support long-term GAS biofilm formation, with biofilms formed closely resembling those seen in vivo. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
9. Development and optimization of ciprofloxacin-loaded gelatin microparticles by single-step spray-drying technique.
- Author
-
Silva, Dina M., Vyas, Heema Kumari Nilesh, Sanderson-Smith, Martina L., and Sencadas, Vitor
- Subjects
- *
CIPROFLOXACIN , *MECHANICAL loads , *GELATIN , *SPRAY drying , *DRUG delivery systems , *PHARMACODYNAMICS - Abstract
Polymeric particles are a versatile class of local or systemic drug delivery systems, used to improve drugs pharmacokinetics and pharmacodynamics along with patient compliance. Herein, we report a rapid, scalable, and optimized method to encapsulate ciprofloxacin (CPx), a poor water soluble antimicrobial agent, in gelatin microparticles by single step processing via spray-drying of an aqueous solution. The developed particles show mainly a wrinkle morphology with a unimodal distribution, with mean diameters ranging between 2 and 4 μm, depending on the processing conditions. The encapsulation of 1, 2 and 5 wt% CPx narrows the size distribution (1–3 μm). In vitro release experiments showed that up to 80% of encapsulated drug is released during the first 6 h, and the release kinetics was best fitted with the Korsmeyer-Peppas model, explained by the superimposition of drug diffusion and polymer chain relaxation. The minimal inhibitory concentrations against S. aureus and E. coli , obtained from pure and encapsulated ciprofloxacin, demonstrated that the spray-drying process does not inhibit the drug's bioactivity or the process feasibility. Thus, spray-drying of protein-drug particle systems is an advantageous method to produce microparticles with potential to lung delivery systems. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.
- Author
-
Frost, Hannah R., Laho, Delphine, Sanderson-Smith, Martina L., Licciardi, Paul, Donath, Susan, Curtis, Nigel, Kado, Joseph, Dale, James B., Steer, Andrew C., and Smeesters, Pierre R.
- Subjects
- *
ANTIGEN-antibody reactions , *COMMUNICABLE diseases , *ENZYME-linked immunosorbent assay , *PEPTIDES , *SERODIAGNOSIS , *SKIN diseases , *STREPTOCOCCAL diseases , *VACCINES - Abstract
Background. Group A Streptococcus (GAS) skin infections are particularly prevalent in developing nations. The GAS M protein, by which strains are differentiated into >220 different emm types, is immunogenic and elicits protective antibodies. A major obstacle for vaccine development has been the traditional understanding that immunity following infection is restricted to a single emm type. However, recent evidence has led to the hypothesis of immune cross-reactivity between emm types. Methods. We investigated the human serological response to GAS impetigo in Fijian schoolchildren, focusing on 3 major emm clusters (E4, E6, and D4). Pre- and postinfection sera were assayed by enzyme-linked immunosorbent assay with N-terminal M peptides and bactericidal assays using the infecting-type strain, emm cluster-related strains, and nonrelated strains. Results. Twenty of the 53 paired sera demonstrated a =4-fold increase in antibody titer against the infecting type. When tested against all cluster-related M peptides, we found that 9 of 17 (53%) paired sera had a =4-fold increase in antibody titer to cluster-related strains as well. When grouped by cluster, the mean change to cluster-related emm types in E4 and E6 was >4-fold (5.9-fold and 19.5-fold, respectively) but for D4 was 3.8-fold. The 17 paired sera were tested in bactericidal assays against selected cluster-related and nonrelated strains. While the responses were highly variable, numerous instances of cross-reactive killing were observed. Conclusions. These data demonstrate that M type-specific and cross-reactive immune responses occur following skin infection. The cross-reactive immune responses frequently align with emm clusters, raising new opportunities to design multivalent vaccines with broad coverage. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. The Plasminogen-Binding Group A Streptococcal M Protein-Related Protein Prp Binds Plasminogen via Arginine and Histidine Residues.
- Author
-
Sanderson-Smith, Martina L., Dowton, Mark, Ranson, Marie, and Walker, Mark J.
- Subjects
- *
STREPTOCOCCUS pyogenes , *PATHOGENIC microorganisms , *PLASMINOGEN , *PROTEINS , *STREPTOCOCCUS , *MUTAGENESIS - Abstract
The migration of the human pathogen Streptococcus pyogenes (group A streptococcus) from localized to deep tissue sites may result in severe invasive disease, and sequestration of the host zymogen plasminogen appears crucial for virulence. Here, we describe a novel plasminogen-binding M protein, the plasminogen-binding group A streptococcal M protein (PAM)-related protein (Prp). Prp is phylogenetically distinct from previously described plasminogen-binding M proteins of group A, C, and G streptococci. While competition experiments indicate that Prp binds plasminogen with a lower affinity than PAM (50% effective concentration = 0.34 µM), Prp nonetheless binds plasminogen with high affinity and at physiologically relevant concentrations of plasminogen (Kd = 7.8 nM). Site-directed mutagenesis of the putative plasminogen binding site indicates that unlike the majority of plasminogen receptors, Prp does not interact with plasminogen exclusively via lysine residues. Mutagenesis to alanine of lysine residues Lys96 and Lys101 reduced but did not abrogate plasminogen binding by Prp. Plasminogen binding was abolished only with the additional mutagenesis of Arg107 and His108 to alanine. Furthermore, mutagenesis of Arg107 and His108 abolished plasminogen binding by Prp despite the presence of Lys96 and Lys101 in the binding site. Thus, binding to plasminogen via arginine and histidine residues appears to be a conserved mechanism among plasminogen-binding M proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
12. A highly sensitive 3base™ assay for detecting Streptococcus pyogenes in saliva during controlled human pharyngitis.
- Author
-
Indraratna, Anuk D., Mytton, Sacha, Ricafrente, Alison, Millar, Doug, Gorman, Jody, Azzopardi, Kristy I., Frost, Hannah R., Osowicki, Joshua, Steer, Andrew C., Skropeta, Danielle, and Sanderson-Smith, Martina L.
- Subjects
- *
STREPTOCOCCUS pyogenes , *SALIVA , *PHARYNGITIS , *MORTALITY , *GRAM-positive bacteria - Abstract
Streptococcus pyogenes (Group A Streptococcus; GAS) is a Gram-positive bacterium responsible for substantial human mortality and morbidity. Conventional diagnosis of GAS pharyngitis relies on throat swab culture, a low-throughput, slow, and relatively invasive 'gold standard'. While molecular approaches are becoming increasingly utilized, the potential of saliva as a diagnostic fluid for GAS infection remains largely unexplored. Here, we present a novel, high-throughput, sensitive, and robust speB qPCR assay that reliably detects GAS in saliva using innovative 3base™ technology (Genetic Signatures Limited, Sydney, Australia). The assay has been validated on baseline, acute, and convalescent saliva samples generated from the C ontrolled H uman I nfection for V accination A gainst S treptococcus (CHIVAS-M75) trial, in which healthy adult participants were challenged with emm75 GAS. In these well-defined samples, our high-throughput assay outperforms throat culture and conventional qPCR in saliva respectively, affirming the utility of the 3base™ platform, demonstrating the feasibility of saliva as a diagnostic biofluid, and paving the way for the development of novel non-invasive approaches for the detection of GAS and other oropharyngeal pathogens. [Display omitted] • Group A Streptococcus (GAS) is a human pathogen of global significance. • Diagnosis traditionally relies on throat culture which is slow and low-throughput. • We have developed a novel saliva-based PCR using 3base™ technology. • It has been validated among a cohort of patients from a human challenge model. • The saliva PCR exhibits greater sensitivity than throat culture. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Host Responses to Group A Streptococcus: Cell Death and Inflammation.
- Author
-
Tsatsaronis, James A., Walker, Mark J., and Sanderson-Smith, Martina L.
- Subjects
- *
STREPTOCOCCUS , *INFLAMMATION , *CELL death , *LEUCOCYTES , *EPITHELIAL cells , *APOPTOSIS - Abstract
Infections caused by group A Streptococcus (GAS) are characterized by robust inflammatory responses and can rapidly lead to life-threatening disease manifestations. However, host mechanisms that respond to GAS, which may influence disease pathology, are understudied. Recent works indicate that GAS infection is recognized by multiple extracellular and intracellular receptors and activates cell signalling via discrete pathways. Host leukocyte receptor binding to GAS-derived products mediates release of inflammatory mediators associated with severe GAS disease. GAS induces divergent phagocyte programmed cell death responses and has inflammatory implications. Epithelial cell apoptotic and autophagic components are mobilized by GAS infection, but can be subverted to ensure bacterial survival. Examination of host interactions with GAS and consequences of GAS infection in the context of cellular receptors responsible for GAS recognition, inflammatory mediator responses, and cell death mechanisms, highlights potential avenues for diagnostic and therapeutic intervention. Understanding the molecular and cellular basis of host symptoms during severe GAS disease will assist the development of improved treatment regimens for this formidable pathogen. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
14. Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM)
- Author
-
Figuera-Losada, Mariana, Ranson, Marie, Sanderson-Smith, Martina L., Walker, Mark J., Castellino, Francis J., and Prorok, Mary
- Subjects
- *
PLASMINOGEN , *ACTIVATION (Chemistry) , *PEPTIDES , *STREPTOCOCCUS , *STREPTOKINASE , *PLASMIN , *SERINE proteinases , *BINDING sites - Abstract
Abstract: In vertebrates, fibrinolysis is primarily carried out by the serine protease plasmin (Pm), which is derived from activation of the zymogen precursor, plasminogen (Pg). One of the most distinctive features of Pg/Pm is the presence of five homologous kringle (K) domains. These structural elements possess conserved Lys-binding sites (LBS) that facilitate interactions with substrates, activators, inhibitors and receptors. In human Pg (hPg), K2 displays weak Lys affinity, however the LBS of this domain has been implicated in an atypical interaction with the N-terminal region of a bacterial surface protein known as PAM (Pg-binding group A streptococcal M-like protein). A direct correlation has been established between invasiveness of group A streptococci and their ability to bind Pg. It has been previously demonstrated that a 30-residue internal peptide (VEK-30) from the N-terminal region of PAM competitively inhibits binding of the full-length parent protein to Pg. We have attempted to determine the effects of this ligand–protein interaction on the regulation of Pg zymogen activation and conformation. Our results show minimal effects on the sedimentation velocity coefficients (S°20,w) of Pg when associated to VEK-30 and a direct relationship between the concentration of VEK-30 or PAM and the activation rate of Pg. These results are in contrast with the major conformational changes elicited by small-molecule activators of Pg, and point towards a novel mechanism of Pg activation that may underlie group A streptococcal (GAS) virulence. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
15. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection.
- Author
-
Walker, Mark J., Hollands, Andrew, Sanderson-Smith, Martina L., Cole, Jason N., Kirk, Joshua K., Henningham, Anna, McArthur, Jason D., Dinkla, Katrin, Aziz, Ramy K., Kansal, Rita G., Simpson, Amelia J., Buchanan, John T., Chhatwal, Gursharan S., Kotb, Malak, and Nizet, Victor
- Subjects
- *
STREPTOCOCCAL diseases , *NECROTIZING fasciitis , *TOXIC shock syndrome , *FIBRINOLYTIC agents , *IMMUNE system , *CYSTEINE proteinases - Abstract
Most invasive bacterial infections are caused by species that more commonly colonize the human host with minimal symptoms. Although phenotypic or genetic correlates underlying a bacterium's shift to enhanced virulence have been studied, the in vivo selection pressures governing such shifts are poorly understood. The globally disseminated M1T1 clone of group A Streptococcus (GAS) is linked with the rare but life-threatening syndromes of necrotizing fasciitis and toxic shock syndrome. Mutations in the GAS control of virulence regulatory sensor kinase (covRS) operon are associated with severe invasive disease, abolishing expression of a broad-spectrum cysteine protease (SpeB) and allowing the recruitment and activation of host plasminogen on the bacterial surface. Here we describe how bacteriophage-encoded GAS DNase (Sda1), which facilitates the pathogen's escape from neutrophil extracellular traps, serves as a selective force for covRS mutation. The results provide a paradigm whereby natural selection exerted by the innate immune system generates hypervirulent bacterial variants with increased risk of systemic dissemination. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
16. Characterizing the role of tissue-type plasminogen activator in a mouse model of Group A streptococcal infection.
- Author
-
Ly, Diane, Donahue, Deborah, Walker, Mark J., Ploplis, Victoria A., McArthur, Jason D., Ranson, Marie, Castellino, Francis J., and Sanderson-Smith, Martina L.
- Subjects
- *
TISSUE plasminogen activator , *STREPTOCOCCAL diseases , *PLASMINOGEN activators , *PLASMINOGEN , *STREPTOCOCCUS pyogenes , *PLASMIN , *MICE - Abstract
Plasmin(ogen) acquisition is critical for invasive disease initiation by Streptococcus pyogenes (GAS). Host urokinase plasminogen activator (uPA) plays a role in mediating plasminogen activation for GAS dissemination, however the contribution of tissue-type plasminogen activator (tPA) to GAS virulence is unknown. Using novel tPA-deficient ALBPLG1 mice, our study revealed no difference in mouse survival, bacterial dissemination or the pathology of GAS infection in the absence of tPA in AlbPLG1/tPA −/− mice compared to AlbPLG1 mice. This study suggests that tPA has a limited role in this humanized model of GAS infection, further highlighting the importance of its counterpart uPA in GAS disease. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. Human glycan expression patterns influence Group A streptococcal colonization of epithelial cells.
- Author
-
De Oliveira, David M. P., Everest-Dass, Arun, Hartley-Tassell, Lauren, Day, Christopher J., Indraratna, Anuk, Brouwer, Stephan, Cleary, Ailish, Kautto, Liisa, Gorman, Jody, Packer, Nicolle H., Jennings, Michael P., Walker, Mark J., and Sanderson-Smith, Martina L.
- Abstract
Colonization of the oropharynx is the initial step in Group A Streptococcus (GAS) pharyngeal infection. We have previously reported that the highly virulent M1T1 GAS clone attaches to oral epithelial cells via M1 protein interaction with blood group antigen carbohydrate structures. Here, we have identified that colonization of human oral epithelial cells by GAS serotypes M3 and M12 is mediated by human blood group antigens [ABO(H)] and Lewis (Le) antigen expression. Removal of linkage-specific fucose, galactose, N-acetylgalactosamine, and sialic acid modulated GAS colonization, dependent on host ABO(H) blood group and Le expression profile. Furthermore, N-linked glycans from human salivary glycoproteins, when released and purified, were potent inhibitors of M1, M3, and M12 GAS colonization ex vivo. These data highlight the important role played by human protein glycosylation patterns in GAS attachment to oral epithelial cell surfaces. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Group A Streptococcus Modulates Host Inflammation by Manipulating Polymorphonuclear Leukocyte Cell Death Responses.
- Author
-
Tsatsaronis, James a., Ly, Diane, Pupovac, aleta, Goldmann, Oliver, Rohde, Manfred, Taylor, Jude M., Walker, Mark J., Medina, Eva, and Sanderson-Smith, Martina L.
- Published
- 2015
- Full Text
- View/download PDF
19. Preferential Acquisition and Activation of Plasminogen Glycoform II by PAM Positive Group A Streptococcal Isolates.
- Author
-
De Oliveira, David M. P., Law, Ruby H. P., Ly, Diane, Cook, Simon M., Quek, Adam J., McArthur, Jason D., Whisstock, James C., and Sanderson-Smith, Martina L.
- Subjects
- *
PLASMINOGEN , *PLASMINOGEN activators , *GLYCOSYLATION , *STREPTOCOCCUS , *SURFACE plasmon resonance , *BINDING sites - Abstract
Plasminogen (Pig) circulates in the host as two predominant glycoforms. Glycoform I Pig (Gl-Plg) contains glycosylation sites at Asn289 and Thr346, whereas glycoform II Pig (GH-Plg) is exclusively glycosylated at Thr346. Surface plasmon resonance experiments demonstrated that Pig binding group A streptococcal M protein (PAM) exhibits comparative equal affinity for GI- and Gll-Plg in the "closed" conformation (for Gll-Plg, KD = 27.4 nM; for Gl-Plg, KD = 37.0 nM). When Pig was in the "open" conformation, PAM exhibited an 11-fold increase in affinity for Gll-Plg (KD = 2.8 nM) compared with that for Gl-Plg (KD = 33.2 nM). The interaction of PAM with Pig is believed to be mediated by lysine binding sites within kringle (KR) 2 of Pig. PAM–Gl-Plg interactions were fully inhibited with 100 mM lysine analogue f-aminocaproic acid (ϵACA), whereas PAM–Gll-Plg interactions were shown to be weakened but not inhibited in the presence of 400 mM ϵACA In contrast, binding to the KR1–3 domains of Gll-Plg (angiostatin) by PAM was completely inhibited in the presence 5 mM eACA. Along with PAM, emm pattern D GAS isolates express a phenotypically distinct SK variant (type 2b SK) that requires Pig ligands such as PAM to activate Pig. Type 2b SK was able to generate an active site and activate Gll-Plg at a rate significantly higher than that of Gl-Plg when bound to PAM. Taken together, these data suggest that GAS selectively recruits and activates Gll-Plg. Furthermore, we propose that the interaction between PAM and Pig may be partially mediated by a secondary binding site outside of KR2, affected by glycosylation at Asn289. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
20. Site-restricted plasminogen activation mediated by group A streptococcal streptokinase variants.
- Author
-
COOK, Simon M., SKORA, Amanda, WALKER, Mark J., SANDERSON-SMITH, Martina L., and MCARTHUR, Jason D.
- Subjects
- *
STREPTOCOCCUS pyogenes , *PLASMINOGEN activators , *STREPTOKINASE , *THROMBOLYTIC therapy , *FIBRINOGEN , *PLASMINOGEN - Abstract
SK (streptokinase) is a secreted plasminogen activator and virulence factor of GAS (group A Streptococcus). Among GAS isolates, SK gene sequences are polymorphic and are grouped into two sequence clusters (cluster type-1 and cluster type- 2) with cluster type-2 being further classified into subclusters (type-2a and type-2b). In the present study, we examined the role of bacterial and host-derived cofactors in SK-mediated plasminogen activation. All SK variants, apart from type-2b, can form an activator complex with Glu-Plg (Glu-plasminogen). Specific ligand-binding-induced conformational changes in Glu- Plg mediated by fibrinogen, PAM (plasminogen-binding group A streptococcal M protein), fibrinogen fragment D or fibrin, were required for type-2b SK to form a functional activator complex with Glu-Plg. In contrast with type-1 and type-2a SK, type-2b SK activator complexes were inhibited by a2-antiplasmin unless bound to fibrin or to the GAS cell-surface via PAMin combination with fibrinogen. Taken together, these data suggest that type-2b SK plasminogen activation may be restricted to specific microenvironments within the host such as fibrin deposits or the bacterial cell surface through the action of a2-antiplasmin. We conclude that phenotypic SK variation functionally underpins a pathogenic mechanismwhereby SK variants differentially focus plasminogen activation, leading to specific niche adaption within the host. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
21. Plasmin(ogen) Acquisition by Group A Streptococcus Protects against C3b-Mediated Neutrophil Killing.
- Author
-
Ly, Diane, Taylor, Jude M., Tsatsaronis, James a., Monteleone, Mercedes M., Skora, amanda S., Donald, Cortny a., Maddocks, Tracy, Nizet, Victor, West, Nicholas P., Ranson, Marie, Walker, Mark J., Mcarthur, Jason D., and Sanderson-Smith, Martina L.
- Published
- 2014
- Full Text
- View/download PDF
22. Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.
- Author
-
Tsatsaronis, James A., Hollands, Andrew, Cole, Jason N., Maamary, Peter G., Gillen, Christine M., Ben Zakour, Nouri L., Kotb, Malak, Nizet, Victor, Beatson, Scott A., Walker, Mark J., and Sanderson-Smith, Martina L.
- Subjects
- *
SYSTEMS biology , *NATURAL immunity , *STREPTOCOCCUS , *SEROTYPES ,DEVELOPING countries - Abstract
In Western countries, invasive infections caused by M1T1 serotype group A Streptococcus (GAS) are epidemiologically linked to mutations in the control of virulence regulatory 2-component operon (covRS). In indigenous communities and developing countries, severe GAS disease is associated with genetically diverse non-M1T1 GAS serotypes. Hypervirulent M1T1 covRS mutant strains arise through selection by human polymorphonuclear cells for increased expression of GAS virulence factors such as the DNase Sda1, which promotes neutrophil resistance. The GAS bacteremia isolate NS88.2 (emm 98.1) is a covS mutant that exhibits a hypervirulent phenotype and neutrophil resistance yet lacks the phage-encoded Sda1. Here, we have employed a comprehensive systems biology (genomic, transcriptomic, and proteomic) approach to identify NS88.2 virulence determinants that enhance neutrophil resistance in the non-M1T1 GAS genetic background. Using this approach, we have identified streptococcal collagen-like protein A and general stress protein 24 proteins as NS88.2 determinants that contribute to survival in whole blood and neutrophil resistance in non-M1T1 GAS. This study has revealed new factors that contribute to GAS pathogenicity that may play important roles in resisting innate immune defenses and the development of human invasive infections. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
23. Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation.
- Author
-
McArthur, Jason D., McKay, Fiona C., Ramachandran, Vidiya, Shyam, Priya, Cork, Amanda J., Sanderson-Smith, Martina L., Cole, Jason N., Ringdahl, Ulrika, Sjöbring, Ulf, Ranson, Marie, and Walker, Mark J.
- Subjects
- *
STREPTOKINASE , *STREPTOCOCCUS pyogenes , *PLASMINOGEN activators , *FIBRINOGEN , *MICROBIAL virulence - Abstract
A common mammalian defense mechanism employed to prevent systemic dissemination of invasive bacteria involves occlusion of local microvasculature and encapsulation of bacteria within fibrin networks. Acquisition of plasmin activity at the bacterial cell surface circumvents this defense mechanism, allowing invasive disease initiation. To facilitate this process, S. pyogenes secretes streptokinase, a plasminogen-activating protein. Streptokinase polymorphism exhibited by S. pyogenes isolates is well characterized. However, the functional differences displayed by these variants and the biological significance of this variation has not been elucidated. Phylogenetic analysis of ska sequences from 28 S. pyogenes isolates revealed 2 main sequence clusters (clusters 1 and 2). All strains secreted streptokinase, as determined by Western blotting, and were capable of acquiring cell surface plasmin activity after incubation in human plasma. Whereas culture supernatants from strains containing cluster 1 ska alleles also displayed soluble plasminogen activation activity, supernatants from strains containing cluster 2 ska alleles did not. Furthermore, plasminogen activation activity in culture supernatants from strains containing cluster 2 ska alleles could only be detected when plasminogen was prebound with fibrinogen. This study indicates that variant streptokinase proteins secreted by S. pyogenes isolates display differing plasminogen activation characteristics and may therefore play distinct roles in disease pathogenesis. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
24. Trigger for group A streptococcal M1T1 invasive disease.
- Author
-
Cole, Jason N., McArthur, Jason D., McKay, Fiona C., Sanderson-Smith, Martina L., Cork, Amanda J., Ranson, Marie, Rohde, Manfred, Itzek, Andreas, Hongmin Sun, Ginsburg, David, Kotb, Malak, Nizet, Victor, Chhatwal, G. S., and Walker, Mark J.
- Subjects
- *
STREPTOCOCCAL diseases , *CYSTEINE proteinases , *MICROBIAL virulence , *PLASMINOGEN , *TRANSGENIC mice - Abstract
The article presents a study which investigated the trigger factor for group A streptococcal M1T1 invasive disease. The characterization and M1T1 5448 and cysteine protease SpeB is discussed. The progression of the virulence of the wild-type strain in humanized plasminogen transgenic mice is examined. A description of SpeB activity of 5448 in vivo isolates is provided.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.